^
No biomarker
Thymoma
GEM-CAP
Sensitive: A2 - Guideline
No biomarker
Thymoma
LV5FU2
Sensitive: A2 - Guideline
No biomarker
Thymoma
CaT
Sensitive: A2 - Guideline
No biomarker
Thymoma
VIP
Sensitive: A2 - Guideline
No biomarker
Thymoma
CAP
Sensitive: A2 - Guideline
No biomarker
Thymoma
etoposide IV
Sensitive: A2 - Guideline
No biomarker
Thymoma
ifosfamide
Sensitive: A2 - Guideline
No biomarker
Thymoma
CAP + prednisone
Sensitive: A2 - Guideline
No biomarker
Thymoma
ADOC
Sensitive: A2 - Guideline
No biomarker
Thymoma
EP
Sensitive: A2 - Guideline
No biomarker
Thymoma
carboplatin
Sensitive: A2 - Guideline
No biomarker
Thymoma
pembrolizumab
Resistant: A2 - Guideline
No biomarker
Thymoma
gemcitabine
Sensitive: A2 - Guideline
No biomarker
Thymoma
paclitaxel
Sensitive: A2 - Guideline
No biomarker
Thymoma
pemetrexed
Sensitive: A2 - Guideline
No biomarker
Thymoma
prednisone + octreotide
Sensitive: A2 - Guideline
No biomarker
Thymoma
octreotide
Sensitive: A2 - Guideline
No biomarker
Thymoma
everolimus
Sensitive: A2 - Guideline
IGF1R expression
Thymoma
everolimus
Resistant: C3 – Early Trials
EIF4EBP1 expression
Thymoma
everolimus
Resistant: C3 – Early Trials
PD-L1 overexpression
Thymoma
pembrolizumab
Sensitive: C4 – Case Studies